Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences
Abstract
:1. Introduction
Looking at the matter thus, we see that the common dictum, that orthodoxy itself has been the mother of rationalism, is in some measure well founded. It is not simply that orthodoxy was pre-occupied with doctrine and the framing of dogma, for these have been no less a concern of the wildest mystics. It is rather that orthodoxy found in the construction of dogma and doctrine no way to do justice to the non-rational aspect of its subject. So far from keeping the non-rational element in religion alive in the heart of religious experience, orthodox Christianity manifestly failed to recognize its value, and by this failure gave to the idea of God a one-sidedly intellectualistic and rationalistic interpretation.
As far as I was concerned—as a rationalist, an atheist, a scientist by training—this was the realm of gods and fairies and of no use to the great human project of trying to retain a foothold on the planet for future generations.
2. Mental Health in Global Perspective
In the 1970s and 80s, several studies were published showing that S/R were generally associated with better mental health, and psychiatry residency programs began incorporating this topic in their curricula. In 2016, the World Psychiatry Association published a position statement on spirituality and religion in psychiatry urging the inclusion of S/R on clinical encounters and training with the goal of providing a more holistic and comprehensive form of mental health care.
3. Psychedelic Treatment and Mental Health
4. The Problem of Defining Religious and Spiritual Experiences
subjects for whom spirituality and religion were highly important had a healthier neural structure than did those for whom spirituality and religion held medium, low, or no importance.
Does the degree to which one reports having had a spiritual experience predict one’s beneficial outcomes? The answer appears to be yes. Across a number of studies scores on the MEQ is predictive of therapeutic success. This suggests that the subjective experience of a psychedelic state may be key to treatment outcomes—and this brings the study of spiritual experience to center stage in the study of psychedelics in general.
Mystical experiences, characterized by a dissolution of the self and profound feelings of interconnectedness, transcend our ordinary conscious awareness. In our usual state of consciousness, we perceive ourselves as separate individuals, distinct from everything and everyone else. However, in certain circumstances, this sense of self can diminish, merging with and becoming part of the broader existence.
5. Christian Responses: Four Options
6. Conclusions: Recognizing Diversity within the Christian Community
Funding
Conflicts of Interest
1 | In his well-known book The Varieties of Religious Experience, James (2002) notes that, “Among the visions and messages some have always been too patently silly, among the trances and convulsive seizures some have been too fruitless for conduct and character, to pass themselves off as significant, still less as divine. In the history of Christian mysticism the problem how to discriminate between such messages and experiences as were really divine miracles, and such others as the demon in his malice was able to counterfeit, thus making the religious person twofold more the child of hell he was before, has always been a difficult one to solve, needing all the sagacity and experience of the best directors of conscience”. |
2 | Yaden and Newberg (2022, p. 357) argue that psychedelic therapy, in some ways, provides a laboratory for being able to study religious and spiritual experiences, which we have not been able to do before. They argue that, “With psychedelics, on the other hand, there is a consistent chemical trigger, and a relatively reliable effect, even though the subjective experience is itself highly complex and is impacted by beliefs as well as one’s clinical and cultural context”. |
3 | With regard to this research, it is noted that, “The present study extends previous observations showing that psilocybin can occasion mystical-type experiences having sustained personal and spiritual significance (Pahnke 1963; Doblin 1991; Griffiths et al. 2006, 2008). Two volunteer-rated measures of mystical-type experience completed at the end of the session days showed dose-related increases, with 72% of volunteers fulfilling criteria for having had a “complete” mystical experience at either or both of the two highest dose sessions. Retrospective ratings of mystical experience and spiritual significance did not diminish in time. One month after either or both the two highest dose sessions, 83% of participants rated the experience as the single most or among the 5 most spiritually significant experiences of their life”. |
4 | Richards (2016, p. 6) suggests that, “There is no question in my mind that, when used in accordance with medical guidelines, with skilled preparation and guidance in responsibly monitored, legal environments, psilocybin and similar substances are indeed molecules that can facilitate beneficial and often sacred experiences”. |
5 | The Church in North America has a mixed response to accepting those with mental health challenges. As Lehmann et al. (2022) argue, many churches are hospitable. Yet, a major challenge remains in that, “some of those attending American churches and congregations hold certain attitudes and theological beliefs that fail to promote a sense of belonging for those who have a mental health diagnosis. People living with mental illness can feel marginalized within the church if a sense of belonging is not actively fostered”. |
References
- Allison, Dale. 2016. Night Comes: Death, Imagination and the Last Things. Grand Rapids: Eerdmans. [Google Scholar]
- Alshaikhli, Hisham, Redhwan Ahmed Al-Naggar, and Gwen Erlam. 2021. Effectiveness of Psilocybin on Depression: A Qualitative Study. Electronic Journal of General Medicine 18: 296. [Google Scholar] [CrossRef]
- American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Publishing. [Google Scholar] [CrossRef]
- Barrett, Frederick S., Matthew P. Bradstreet, Jeannie-Marie S. Leoutsakos, Matthew W. Johnson, and Roland R. Griffiths. 2016. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology 30: 1279–95. [Google Scholar] [CrossRef] [PubMed]
- Bogenschutz, Michael P., Alyssa A. Forcehimes, Jessica A. Pommy, Claire E. Wilcox, Paolo C. R. Barbosa, and Rick J. Strassman. 2015. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology 29: 289–99. [Google Scholar] [CrossRef] [PubMed]
- Carbonaro, Theresa M., Matthew P. Bradstreet, Frederick S. Barrett, Katherine A. MacLean, Robert Jesse, Matthew W. Johnson, and Roland R. Griffiths. 2016. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology 30: 1268–78. [Google Scholar] [CrossRef]
- Carhart-Harris, Robin L., and D. J. Nutt. 2010. User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Use 15: 283–300. [Google Scholar] [CrossRef]
- Carhart-Harris, Robin L., Robert Leech, Peter J. Hellyer, Murray Shanahan, Amanda Feilding, Enzo Tagliazucchi, Dante R. Chialvo, and David Nutt. 2014. The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience 8: 20. [Google Scholar] [CrossRef]
- COVID-19 Mental Disorders Collaborators. 2021. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 398: 1700–12. [Google Scholar] [CrossRef]
- Davis, Alan K., Frederick S. Barrett, Darrick G. May, Mary P. Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan, and Roland R. Griffiths. 2021. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry 78: 481–89. [Google Scholar] [CrossRef]
- Doblin, Richard. 1991. Pahnke’s Good Friday experiment: A long-term follow-up and methodological critique. The Journal of Transpersonal Psychology 23: 1–28. [Google Scholar]
- Ehrenreich, Barbara. 2014. Living with a Wild God. New York: Twelve. [Google Scholar]
- Exline, Julie J., William A. Schutt, Kathleen C. Pait, and Joshua A. Wilt. 2022. Do psychedelic trips open the door to messagesmfrom God, spirits, transcendent realities, or the devil? Links with attitudes about psychedelics, opinions about legalization, and interest in personal use. International Journal for the Psychology of Religion. [Google Scholar] [CrossRef]
- Griffiths, Roland R., William A. Richards, Matthew W. Johnson, Una D. McCann, and Robert Jesse. 2008. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 22: 621–32. [Google Scholar] [CrossRef] [PubMed]
- Griffiths, Roland R., William A. Richards, Una D. McCann, and Robert Jesse. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187: 268–83. [Google Scholar] [CrossRef]
- Griffiths, Roland R., Matthew W. Johnson, Michael A. Carducci, Michael Umbricht, William A. Richards, Brian D. Richards, Brian P. Cosimano, and Margaret A. Klinedinst. 2016. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology 30: 1181–97. [Google Scholar] [CrossRef]
- Griffiths, Roland R., Matthew W. Johnson, William A. Richards, Brian D. Richards, Una McCann, and Robert Jesse. 2011. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 218: 649–65. [Google Scholar] [CrossRef]
- Halpern, John H., Arturo G. Lerner, and Torsten Passie. 2018. A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Current Topics in Behavioral Neurosciences 36: 333–60. [Google Scholar] [CrossRef]
- James, William. 2002. The Varieties of Religious Experience. New York: Dover. [Google Scholar]
- Lehmann, Curtis S., William B. Whitney, Jean Un, Jennifer S. Payne, Maria Simanjuntak, Stephen Hamilton, Tsegamlak Worku, and Nathaniel A. Fernandez. 2022. Hospitality Towards People with Mental Illness in the Church: A Cross-cultural Qualitative Study. Pastoral Psychology 71: 1–27. [Google Scholar] [CrossRef]
- Lucchetti, Giancarlo, Harold G. Koenig, and Alessandra Lamas Granero Lucchetti. 2021. Spirituality, religiousness, and mental health: A review of the current scientific evidence. World Journal of Clinical Cases 9: 7620–31. [Google Scholar] [CrossRef]
- Miller, Lisa. 2021. The Awakened Brain: The Psychology of Spirituality and our Search for Meaning. London: Penguin House. [Google Scholar]
- Nichols, David. 2016. Psychedelics. Pharmacological Reviews 68: 264–355. [Google Scholar] [CrossRef]
- NIDA. 2021. From the Director. Available online: https://nida.nih.gov/publications/research-reports/hallucinogens-dissociative-drugs/director (accessed on 19 December 2022).
- Otto, Rudolf. 1958. The Idea of the Holy. Oxford: Oxford University Press. [Google Scholar]
- Pahnke, Walter M. 1963. Thesis Presented to the President and Fellows of Harvard University for the Ph.D. in Religion and Society. In Drugs and Mysticism: An Analysis of the Relationship between Psychedelic Drugs and the Mystical Consciousness. Cambridge: Harvard University. [Google Scholar]
- Podrebarac, Samantha K., Kelley C. O’Donnell, Sarah E. Mennenga, Lindsey T. Owens, Tara C. Malone, Jessie H. Duane, and Michael P. Bogenschutz. 2021. Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence. Spirituality in Clinical Practice 8: 177–87. [Google Scholar] [CrossRef]
- Richards, Williams. 2016. Sacred Knowledge. Psychedelics and Religious Experiences. New York: Columbia University Press. [Google Scholar]
- Ross, Stephen, Anthony Bossis, Jeffrey Guss, Jeffrey Agin-Liebes, Tara Malone, Barry Cohen, Sarah E. Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb, and et al. 2016. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology 30: 1165–80. [Google Scholar] [CrossRef] [PubMed]
- Rucker, James, and Allan Young. 2021. Psilocybin: From Serendipity to Credibility? Frontiers in Psychiatry 12: 659044. [Google Scholar] [CrossRef] [PubMed]
- Sosteric, Mike. 2018. Everyone has a connection experience: Prevalence, Confusions, Interference, and Redefinition. Spirituality Studies 4: 17–23. [Google Scholar]
- Taves, Ann. 2009. Religious Experience Reconsidered: A Building-Block Approach to the Study of Religion and Other Special Things. Princeton: Princeton University Press. [Google Scholar]
- Wells, Greta. 2015. Pastoral Care and the Complexity of Mental Illness in Pentecostal and Evangelical Churches. Available online: https://www.abc.net.au/religion/pastoral-care-and-the-complexity-of-mental-illness-in-pentecosta/10097776 (accessed on 2 August 2023).
- Wildman, Wesley. 2011. Religious and Spiritual Experiences. Cambridge: Cambridge University Press. [Google Scholar]
- Wilkins, Roger, Esperanza Vera-Toscano, Ferdi Botha, Mark Wooden, and Trong-Anh Trinh. 2022. The Household, Income and Labour Dynamics in Australia Survey: Selected Findings from Waves 1 to 20. Melbourne: Melbourne Institute, Applied Economic & Social Research, University of Melbourne. [Google Scholar]
- World Health Organization. 2012. Global Burden of Mental Disorders and the Need for a Comprehensive, Coordinated Response from Health and Social Workers at the Country Level: Report by the Secretariat. Geneva: World Health Organization. Available online: https://apps.who.int/iris/handle/10665/23741 (accessed on 30 March 2023).
- World Health Organization. 2022a. Mental Disorders. Available online: https://www.who.int/news-room/fact-sheets/detail/mental-disorders (accessed on 7 December 2022).
- World Health Organization. 2022b. Mental Health and COVID-19: Early Evidence of the Pandemic’s Impact: Scientific Brief, 2 March 2022. Geneva: World Health Organization. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1 (accessed on 7 December 2022).
- Yaden, David, and Andrew Newberg. 2022. The Varieties of Spiritual Experience: 21st Century Research and Perspectives. Oxford: Oxford University Press. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Macallan, B.C. Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences. Religions 2023, 14, 1312. https://doi.org/10.3390/rel14101312
Macallan BC. Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences. Religions. 2023; 14(10):1312. https://doi.org/10.3390/rel14101312
Chicago/Turabian StyleMacallan, Brian Claude. 2023. "Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences" Religions 14, no. 10: 1312. https://doi.org/10.3390/rel14101312
APA StyleMacallan, B. C. (2023). Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences. Religions, 14(10), 1312. https://doi.org/10.3390/rel14101312